SMTP / IMAP / Topics

Pharmacology

Explore the complete collection by topic.

Why a short ester does not prevent androgenic changes, which effects may persist and how medical treatment differs from sports use.

Oil-depot absorption, ester cleavage, metabolites and the lack of reliable human data behind frequently quoted half-lives.

Aromatization, receptor activity, SHBG and indirect hormonal changes, with a critical look at common combination-use claims.

Liver injury, cardiovascular effects, hormonal suppression and product uncertainty, separated by the available level of evidence.

A simple explanation of the proposed MGF model, the role of IGF-1 and why laboratory mechanisms do not prove product benefits.

Tremor, palpitations, potassium shifts, arrhythmias and poisoning, with warning signs that require urgent medical assessment.

What clomiphene can and cannot establish about hormonal recovery, dose response, long-term use and anti-doping status.

Bile composition, transport, cellular protection and cholesterol stones, with a distinction between mechanisms and clinical benefit.

Older trial findings, a later liver-injury case report, metabolic concerns and the uncertainty of online product composition.

Reversible aromatase inhibition, pharmacokinetics, interactions and the consequences of reduced estrogen in different populations.

Energy signaling, intestinal actions, clearance, drug interactions and the limits of equating a medicine with a supplement.